Organigram (TSXV: OGI) CEO Interview w/ Greg Engel
LIKE us on Facebook: www.facebook.com/mmjinvestor
EXCLUSIVE Interview with CEO, Greg Engel of OrganiGram Inc.
OrganiGram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) is Atlantic Canada’s original licensed producer of medical cannabis. OrganiGram CEO Greg Engel chats with The Cannabis Investor about what makes OGI a unique Canadian Cannabis company and their plans of moving forward and expanding with the growth of medical and expected recreational markets.
CEO INTERVIEW HIGHLIGHTS:
• How OGI is prepping for the recreational market in 2018
• New partnerships for extract and edible based products
• Expansions of massive new production facilities
• Unique growing methods from OGI
• New international market opportunities in Europe and Australia
• Updates on OGI’s Organic Certification process
• Opinions on future Medical and Recreational Marijuana Markets